title: Osteoclastic differentiation of mouse and human monocytes in a plasma clot/biphasic calcium phosphate microparticles composite.
abstract: We recently demonstrated that blood clotted around biphasic calcium phosphate (BCP) microparticles constituted a composite biomaterial that could be used for bone defect filling. In addition, we showed that mononuclear cells, i.e. monocytes and lymphocytes, play a central role in the osteogenic effect of this biomaterial. Hypothesizing that osteoclast progenitors could participate to the pro-osteogenic effect of mononuclear cells we observed previously, we focus on this population through the study of mouse monocyte/macrophage cells (RAW264.7 cell line), as well as human pre-osteoclastic cells derived from mononuclear hematopoietic progenitor cells (monocytes-enriched fraction from peripheral blood). Using monocyte-derived osteoclast progenitors cultured within plasma clot/BCP microparticles composite, we aimed in the present report at the elucidation of transcriptional profiles of genes related to osteoclastogenesis and to bone remodelling. For both human and mouse monocytes, real-time PCR experiments demonstrated that plasma clot/BCP scaffold potentiated the expression of marker genes of the osteoclast differentiation such as Nfactc1, Jdp2, Fra2, Tracp and Ctsk. By contrast, Mmp9 was induced in mouse but not in human cells, and Ctr expression was down regulated for both species. In addition, for both mouse and human precursors, osteoclastic differentiation was associated with a strong stimulation of VegfC and Sdf1 genes expression. At last, using field-emission scanning electron microscopy analysis, we observed the interactions between human monocytes and BCP microparticles. As a whole, we demonstrated that plasma clot/BCP microparticles composite provided monocytes with a suitable microenvironment allowing their osteoclastic differentiation, together with the production of pro-angiogenic and chemoattractant factors.
authors.affiliation: GéPITOs, UMR6235 UFR de Médecine, 28 Avenue de Valombrose, F-06107 NICE, Cedex 2, France.
authors.forename: Caroline C
authors.initials: CC
authors.lastname: Mouline
authors.forename: Danielle
authors.initials: D
authors.lastname: Quincey
authors.forename: Jean-Pierre
authors.initials: JP
authors.lastname: Laugier
authors.forename: Georges F
authors.initials: GF
authors.lastname: Carle
authors.forename: Jean-Michel
authors.initials: JM
authors.lastname: Bouler
authors.forename: Nathalie
authors.initials: N
authors.lastname: Rochet
authors.forename: Jean-Claude
authors.initials: JC
authors.lastname: Scimeca
mesh_terms: D000818:Animals; D001769:Blood; D001777:Blood Coagulation; D016723:Bone Remodeling; D002130:Calcium Phosphates; D002454:Cell Differentiation; D002460:Cell Line; D017886:Durapatite; D020869:Gene Expression Profiling; D006801:Humans; D051379:Mice; D008810:Mice, Inbred C57BL; D009000:Monocytes / Q000166:cytology*; D010010:Osteoclasts / Q000166:cytology*; D010012:Osteogenesis; D010316:Particle Size; D054457:Tissue Scaffolds
chemical_list: D002130:Calcium Phosphates; C485817:beta-tricalcium phosphate; D017886:Durapatite